Search Results

1-6 of 6 results for askedby:"Patsy Calton"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, what steps his Department takes to trace recipients of blood donated by donors identified as having (a) variant Creutzfeldt-Jakob Disease and (b) other blood-borne diseases.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

18 December 2003

For answer on

12 January 2004

Answered on

12 January 2004

Mrs. Calton: To ask the Secretary of State for Health what steps his Department takes to trace recipients of blood donated by donors identified as having (a) variant Creutzfeldt-Jakob Disease and (b) other blood-borne diseases. [145453] Miss Melanie Johnson: The Transfusion Medicine Epidemiology Review is a collaborative project between the United Kingdom National CJD Surveillance Unit (NCJDSU) and United Kingdom Blood Services (UKBS). The main purpose is to investigate whether there is any evidence that Creutzfeldt-Jakob disease or variant Creutzfeldt-Jakob disease may have been transmitted via the blood supply. Variant Creutzfeldt-Jakob disease cases are notified to the UKBS by NCJDSU; a search establishes whether any have acted as donors. Donation records are checked and all components traced through hospital records. Details of all identified recipients are forwarded to NCJDSU for subsequent checking. In the reverse procedure, patients with variant CJD reported to have received blood transfusions are identified by NCJDSU and notified to UKBS. Details of transfusions are traced through hospital records and relevant blood donors identified. The identity of donors is notified to NCJDSU for subsequent checking. The safety of blood used in the National Health Service is of paramount importance. Every reasonable step has been taken to minimise any risks during blood transfusion. The current high levels of safety are achieved by screening out potential high risk donors and then further testing of every unit of donated blood for HIV, Hepatitis B, Hepatitis C, Human T Cell Leukaemia Virus, and Syphilis before it is released to NHS hospitals.

Date

12 January 2004

Reference

145453; 416 c627-8W;416 c625-6W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how his Department monitors compliance by PCTs with the requirement that funds are made available for the implementation of NICE guidance not later than three months after issue; and if he will make a statement; what further plans he has to address...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

12 June 2003

For answer on

23 June 2003

Answered on

23 June 2003

Mrs. Calton: To ask the Secretary of State for Health (1) how his Department monitors compliance by PCTs with the requirement that funds are made available for the implementation of NICE guidance not later than three months after issue; and if he will make a statement; [119669] (2) what further plans he has to address the local variations in prescribing atypical antipsychotic drugs for the treatment of people with schizophrenia; and if he will make a statement; [119670] (3) what measures are being taken to increase the number of primary care trusts who are implementing the National Institute for Clinical Excellence guidance on HTA; [119674] (4) what estimate he has made of the number of people who do not have access to the most modern drugs to treat schizophrenia as set out in the National Institute for Clinical Excellence guidance of June 2002. [119675] Ms Rosie Winterton: The National Institute for Clinical Excellence (NICE) issued guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia in June 2002. It is recommended that atypical antipsychotics should be considered as options for the treatment of schizophrenia. The clinician responsible for prescribing the medication should do so following appropriate assessment of the patient and taking into account the views of the patient (or their advocate if appropriate), and the relative benefits and side effects. The statistics currently available on the use of atypical antipsychotics indicate a continuing rise in the prescribing of these products, but no estimates are available of the number of patients who may not be receiving treatment in accordance with NICE guidance. National health service bodies are under a statutory obligation to fund treatments recommended in NICE technology appraisals. We expect primary care trusts (PCTs) to meet their statutory obligations, and strategic health authorities to follow up any allegations of non- compliance. We last reminded PCTs of their obligations in guidance published in January 2003.

Date

23 June 2003

Reference

407 c580W;407 c584W; 119669;119670;119674;119675

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what procedures there are to monitor whether a terminally ill patient has received an assisted suicide or voluntary euthanasia from (a) a member of the health care team and (b) a family member.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

27 March 2003

Reference

104536; 402 c388W

House

House of Commons

Home Office

To ask the Secretary of State for the Home Department, how many hand-held chemical agent monitors are available in each police force. - Includes no figures.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Home Office

Type

Written questions

Status

Answered

Date

21 March 2003

Reference

102517; 401 c967W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what (a) monitoring and (b) research has been conducted by or for his Department on long waiting times for genito-urinary medicine services; if he will make a statement on the investment by his Department on GUM clinics; and how the investment will...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

25 February 2003

Reference

400 c526-7W;400 c517-8W; 97149;97148;97147

House

House of Commons

House of Commons Commission

To ask the honourable Member for Roxburgh and Berwickshire, representing the House of Commons Commission, what arrangements are in place for monitoring pay and positions by ethnicity, gender and disability on the parliamentary estate; and if he will make a statement. (Holding answer 16 May 2002).

Asked by

Patsy Calton (Liberal Democrat)

Answering body

House of Commons Commission

Type

Written questions

Status

Answered

Date

20 May 2002

Reference

56494; 386 c8W

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher